2nd Annual
Oligonucleotides Chemistry & Therapeutics Europe CongressSeptember 2024 | Amsterdam, Netherlands
Cutting-edge oligo research & therapeutic development to advance innovation and knowledge-share. From new technologies
through to therapeutic success stories, do not miss out on joining us to stay at the forefront of research.
The Oligonucleotides Chemistry & Therapeutics Europe Congress includes...
- Discuss the latest innovations in oligo chemistry & targeted delivery approaches. Presentation will cover aptamer technologies, antisense therapies, modification & nucleoside chemistry as well as peptide-oligo conjugation methods & strategies
- Discover collaborative solutions to oligonucleotides therapeutics analytics – gain invaluable insights into cell-based assay development, in vitro and in vivo imaging as well as advanced computational approaches such as AI/ML and CRISPR/Cas systems
- Gain a comprehensive understanding of oligo & antisense therapeutics case studies & commercialisation approaches. Tap into safety & efficacy development, antisense clinical development and new nucleotides
- Take a deep dive into oligonucleotides therapeutics proof of concepts & new innovations. Key opinion leaders will discuss clinical case studies in gene therapy and therapeutic therapies using oligonucleotides as well as mRNA targeting drugs
2024 Agenda at a Glance
Day One
- Oligo synthesis
- siRNA/RNAi
- Aptamer technologies
- Antisense therapies
- Modification chemistry
- Nucleoside chemistry
- Peptide-oligo conjugation
» Site-specific bioconjugation
- Cell-based assay development
- In vitro and in vivo imaging
- Computational approaches, methods & tools
» AI/ML
» Gene editors
» CRISPR/Cas systems
» Guide-RNA design - Rapid screening analytical methods for oligonucleotides
- Stability testing
Day Two
Part 1 –
- Preclinical development
o Safety assessment
o Efficacy assessment - Clinical development
o Antisense oligonucleotides
o siRNA therapeutics - Commercialization
- New nucleotides
Part 2 –
Oligonucleotides Therapeutics Proof of Concepts & New Innovations
- Clinical case studies in gene therapy and therapeutic therapies using oligonucleotides
- Therapeutic mRNA editing for genetic disorders
- mRNA targeting drugs